At Ferrer the way we do things is just as important as what we do
At Ferrer we play fair, and we make every effort to assure ethical conduct in all our business activities.
And we do so by paying attention not only to what we do, but also, and especially, to how we do it.
Not only are we committed to complying with current regulations: we go one step further, with the conviction that we can only achieve our objectives by behaving with integrity and honesty in all our dealings.
A comprehensive, international Ethics & Compliance System
At Ferrer we have evolved from a criminal risk prevention system to an ethics system, including compliance risk prevention, aligned with the most recognised national and international standards.
Furthermore, as a pharmaceutical company, we comply with the legislation and regulations applicable to our activity, including the standards set out in the codes of good practice of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and we are members of various sectoral associations in different countries where we are operates.
Our system is based on 3 main pillars:
Culture. Commitment, training and awareness-raising
Ferrer’s senior management is deeply committed to an authentic culture of ethics and compliance and actively contributes to fostering this culture.
In 2022, an annual Declaration of Ethical and Regulatory Compliance was signed by the Corporate Management Committee, the Management Committee of Ferrer Spain, Directors and Country Managers of national and international subsidiaries, and local Compliance Officers (more than 100 signatures).
Zero tolerance for corruption
In 2022, to coincide with International Anti-Corruption Day on 9 December, we updated our Corporate Anti-Bribery and Anti-Corruption Policy.
This Policy applies to all Ferrer people, especially in our relations with third parties, both in the public sector (public administration personnel, politicians, etc.) and in the private sector (people from other companies, associations, foundations, etc.).
Furthermore, it is global in scope and, therefore, all Ferrer employees must apply it without exception, regardless of their functions or the country in which they operate.
In addition, to show our unequivocal commitment, we ran an anti-corruption campaign with posters, vinyl stickers and audiovisual resources in all our centres.
Risk management
In recent years we have strengthened our risk management system and, in October 2022, we also put in place a Risk Management Policy, which defines the general framework for action and establishes roles and responsibilities, as well as our own Corporate Risk Map, which is monitored on a regular basis.
In addition, in order to adequately monitor compliance risks (including criminal and anti-corruption risks) at Ferrer, we have implemented improvements and recommendations derived from the review of the Compliance Risk Map in 2022 (both at the corporate level and in the international subsidiaries).
Transparent governance
Management Team
Ferrer’s governance structure consists of the Board of Directors and the Management Committee. In addition, the Board of Directors has an Ethics, Compliance and Audit Advisory Board.
* structure as of 3 April 2023
Board of Directors
Sergi Ferrer-Salat – Chairman
Mario Rovisora – Secretary
Josep Vilarasau – Director
Joan Fanés – Director
Advisory Board to the Board of Directors
Sergi Ferrer-Salat – Chairman
Rafael Abella – Audit Advisor
José Ignacio González – Ethics and Compliance Advisor
Meritxell Casas – Secretary
Beatriz Vila
Beatriz Vila
Chief People & Sustainability Officer
Degree in Psychology from the University of Barcelona with an MBA from ESADE.
Joined Ferrer in 2018. Prior to joining the company, she held People Management positions in a number of multinational companies.
Since joining, she has been responsible for the People and Sustainability area.
Mario Rovirosa
Mario Rovirosa
CEO
Degree in Business Administration with an MBA from ESADE.
He joined Ferrer in 2016 as general manager of the pharmaceutical area and two years later he became CEO.
Before joining Ferrer, he worked for more than 22 years in the pharmaceutical industry in other family-run companies around the world, such as Almirall and Chiesi in Spain and Italy.
Silvia Martín
Silvia Martín
Chief Quality, Regulatory & PV Officer
Graduate in Pharmacy from the University of Barcelona with a postgraduate degree in R&D and Registration Processes in the Pharmaceutical Industry from the University of Barcelona.
She joined Ferrer as a recent graduate in 1999 in the Regulatory Affairs department.
She is currently in charge of Ferrer’s Quality, Regulatory Affairs and Pharmacovigilance departments.
Cecilia Von Ahn
Cecilia Von Ahn
Chief Transformation Officer
Degree in Business and International Management from the Hochschule Bremen (Germany).
She joined Ferrer in 2003 as an intern in the International Area and, after a year in the logistics sector, she returned to Ferrer in 2005 to join the international team.
Over the years, she has held various positions, always at the international level. She is now the corporate director of the transformation office, which promotes the company’s strategic and cross-cutting projects.
Marta Vela
Marta Vela
Chief Operations Officer
Graduate in Technical Industrial Chemical Engineering from the EUETIB (Barcelona College of Industrial Engineering).
She joined the company in 2017, after holding the position of production manager at Novartis for 5 years.
She has previously held positions in industrial operations in other international (Alcon-B.Braun) and national (Esteve) pharmaceutical companies.
She is currently responsible for Ferrer’s Operations area, which includes the pharmaceutical plants, the chemical plant and the logistics and distribution centre.
Ricardo Castrillo
Ricardo Castrillo
Chief Commercial Officer
Degree in Pharmacy from the University of Barcelona with an MBA from ESADE and executive training at SDA Bocconi.
He has extensive experience in the pharmaceutical sector at a national and international level and is a regular collaborator with various business schools.
He held various positions in marketing, sales, innovation and transformation before joining Ferrer in 2018.
He is currently in charge of Ferrer’s commercial area.
David Ferrer
David Ferrer
Chief Financial & Corporate Services Officer
Graduate in Business Administration and Management from the Autonomous University of Barcelona with a leadership development degree from ESADE.
After several years in the field of professional services as a financial auditor and later as a strategy and operations consultant, he joined Ferrer in 2007 as the financial and systems director of one of Ferrer’s subsidiaries.
He is currently in charge of Ferrer’s Finance, Treasury, Management Control, Purchasing, Systems, Customer Service and Internal Audit departments.
Meritxell Casas
Meritxell Casas
Chief Legal Officer
Law Degree from the University of Barcelona, and having completed an SEP and an AMP from ESADE.
She is the Chief Legal Officer of the Ferrer Group companies.
She joined the company in 2015, after holding legal and human resources management positions in various pharmaceutical companies, both in Spain (Salvat) and internationally (Madaus, Rottapharm).
She is currently responsible for Ferrer’s Legal, Industrial Property and Ethics and Compliance departments.
Tatjana Naranda
Tatjana Naranda
Chief R&D Officer
Graduate in Chemistry, with a Master’s Degree in Biochemistry, both from Zagreb University, as well as a doctorate in Molecular Biology from the Autonomous University of Madrid (Severo Ochoa Centre) and an EMBA from the Golden Gate University in San Francisco.
She has many years of experience in pharmaceutical R&D, especially as chief scientific officer at several companies in the San Francisco area.
She joined Alexza in 2005 in the position of business and alliance manager.
She is currently in charge of Ferrer’s R&D.
Jorge Cuneo
Jorge Cuneo
Chief Medical Officer
Degree in Medicine from the University of Buenos Aires.
He has performed different roles in the pharmaceutical industry, both in the medical and commercial areas, having held leadership positions in different countries, regions, and internationally.
Since April 2023, he has held the position of Chief Medical Officer at Ferrer, leading the medical affairs team at the corporate level.
Óscar Pérez
Óscar Pérez
Chief Marketing, Market Access and Business Development Officer
Degree in Pharmacy from the University of Barcelona with an EMBA from ESADE and an AMP from IESE.
He teaches and mentors entrepreneurship at ESADE, UPF and CESIF.
After 18 years in various international and regional sales executive positions at the biopharmaceutical companies Amgen and Celgene, he joined Ferrer in 2018 to lead the creation of a global strategy department.
He is currently responsible for the corporate Marketing, Pricing and Market Access, Business Analysis, Multichannel Strategy and Business Development departments.
Sergi Ferrer-Salat
Sergi Ferrer-Salat
Chairman
Graduate in Economics and Business Studies from the University of Barcelona. He has been Chairman of Ferrer since 1998. His philanthropic and patronage activities include the Ferrer-Salat Music Foundation, which, since 1982, has remained faithful to its commitment to empowering people, mainly those at risk of social exclusion, through music. He has also been very active in charitable work for many years with WWF, Greenpeace and Médecins Sans Frontières (Doctors without Borders).